跳至主要内容
临床试验/NCT01860365
NCT01860365Unknown不适用

Measuring Concerns and Needs of Cancer Patients Referred to Complementary Medicine Treatment Integrated Within the Oncology Service

Carmel Medical Center1 个研究点 分布在 1 个国家目标入组 2,500 人开始时间: 2009年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
2,500
试验地点
1
主要终点
ESAS (Edmonton Symptom Assessment Scale)questionnaire

研究概览

简要总结

In 2007, the Haifa and Western Galilee district of the CHS set out to test the feasibility of integrating complementary medicine (CM) within the CHS Oncology Service. In 2008, the CHS established the Integrative Oncology Program with the goal of addressing patient concerns and improving quality of life parameters during chemotherapy and advanced disease. The study hypothesis is that integrated medicine consultation and treatment provided within the oncology department may improve patients' concerns and well-being.

详细描述

In 2007, the Haifa and Western Galilee district of the CHS set out to test the feasibility of integrating complementary medicine (CM) within the CHS Oncology Service. In 2008, the CHS established the Integrative Oncology Program with the goal of addressing patient concerns and improving quality of life parameters during chemotherapy and advanced disease. The study is purposed to assess concerns, needs and perspectives of patients referred to integrative consultation during chemotherapy and/or advanced cancer; to characterize social demographic and health parameters of patients who consult or avoid integrative medicine consultation; to document complementary medicine use prior and during consultation; to assess if complementary medicine consultation and treatment improve patient's concerns and well-being; and to assess oncology provider and integrative practitioner communications issues concerning integrative care.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with cancer diagnosis receiving chemotherapy and/or surgical treatment who are referred by their oncology provider to complementary medicine consultation
  • •Age older than 18 years

排除标准

  • •Age younger than 18 years

研究组 & 干预措施

Complementary medicine counseling

Experimental

Patients receiving chemotherapy who are referred by their oncology provider to complementary medicine consultation and treatment provided in addition to conventional supportive care

干预措施: Complementary medicine consultation and treatment (Other)

Conventional supportive care

Active Comparator

Patients receiving conventional supportive care

干预措施: Patients receiving conventional supportive care (Other)

结局指标

主要结局

ESAS (Edmonton Symptom Assessment Scale)questionnaire

时间窗: 6-12 weeks(+follow-up 4 months)

Assessing the severity of 10 leading symptoms and well-being

MYCAW (Measure Yourself Concerns and Wellbeing)questionnaire

时间窗: 6-12 weeks(+follow-up 4 months)

Assessing patients'concerns and Wellbeing as well as narrative assessment of integrative care outcomes

EORTC QLQ-C30

时间窗: 6-12 weeks(+follow-up 4 months)

The EORTC quality of life questionnaire (QLQ) is an integrated system for assessing the health related quality of life of cancer patients. The questionnaire includes functional and symptom scales.

次要结局

  • FACIT-Sp-12 questionnaire(2-4 months)
  • Attitudes concerning complementary medicine(6-12 weeks)

研究者

发起方
Carmel Medical Center
申办方类型
Other
责任方
Principal Investigator
主要研究者

Eran Ben-Arye

Integrative oncology Program, Director

Carmel Medical Center

研究点 (1)

Loading locations...

相似试验